doi: 10.1136/bmj.2.5652.290.
Metabolism of 35S-labelled antithyroid drugs in man
- PMID: 4180995
- PMCID: PMC1983143
- DOI: 10.1136/bmj.2.5652.290
Item in Clipboard
Metabolism of 35S-labelled antithyroid drugs in man
Br Med J.
.
Abstract
Differences in the metabolic fate of antithyroid drugs influence the optimal frequency of administration and their therapeutic efficacy. (35)S propylthiouracil differed from the (35)S imidazoles (carbimazole and methimazole) in the more rapid absorption and excretion and the shorter biological half-life in the plasma of the former. Renal function may have a more important influence on the biological half-life of the drugs than thyroid status. Further work is required to determine the optimal frequency of administration for each compound.
Similar articles
-
Biliary excretion of 35 S-labelled propylthiouracil, methimazole and carbimazole in untreated and pentobarbitone pretreated rats.Biochem Pharmacol. 1972 Feb 1;21(3):363-77. doi: 10.1016/0006-2952(72)90348-6. Biochem Pharmacol. 1972. PMID: 4111354 No abstract available.
-
The acclumulation of 35 S-antithyroid drugs by the thyroid gland.J Clin Endocrinol Metab. 1972 May;34(5):847-51. doi: 10.1210/jcem-34-5-847. J Clin Endocrinol Metab. 1972. PMID: 4111035 No abstract available.
-
The metabolism of 35S-labelled antithyroid drugs in thyrotoxic, adenomatous, neoplastic and normal human thyroid.Clin Sci. 1973 Jun;44(6):24P. doi: 10.1042/cs044024p. Clin Sci. 1973. PMID: 4123392 No abstract available.
-
[Metabolism of thioureylene antithyroid drugs--particularly with relationship between intrathyroidal metabolism of the drugs and the mechanisms of action (author's transl)].Rinsho Byori. 1982 Feb;30(2):170-8. Rinsho Byori. 1982. PMID: 6177885 Review. Japanese. No abstract available.
-
Pharmacokinetics of antithyroid drugs.Klin Wochenschr. 1982 Jun 1;60(11):531-9. doi: 10.1007/BF01724208. Klin Wochenschr. 1982. PMID: 6180218 Review. No abstract available.
Cited by
-
Thyroid disorders--management.Br Med J. 1970 Mar 21;1(5698):745-8. doi: 10.1136/bmj.1.5698.745. Br Med J. 1970. PMID: 4191695 Free PMC article. Review. No abstract available.
-
Clinical pharmacokinetics of antithyroid drugs.Clin Pharmacokinet. 1981 Nov-Dec;6(6):401-28. doi: 10.2165/00003088-198106060-00001. Clin Pharmacokinet. 1981. PMID: 6172233 Review.
-
The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients.Br J Clin Pharmacol. 1980 Feb;9(2):137-43. doi: 10.1111/j.1365-2125.1980.tb05823.x. Br J Clin Pharmacol. 1980. PMID: 7356900 Free PMC article.
-
Methimazole as a protectant against cisplatin-induced nephrotoxicity using the dog as a model.Cancer Chemother Pharmacol. 1993;33(1):25-30. doi: 10.1007/BF00686018. Cancer Chemother Pharmacol. 1993. PMID: 8269585
-
Pharmacokinetic properties and bioavailability of methimazole.Clin Pharmacokinet. 1985 Sep-Oct;10(5):443-50. doi: 10.2165/00003088-198510050-00006. Clin Pharmacokinet. 1985. PMID: 4042519
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources